US Stock MarketDetailed Quotes

ELV Elevance Health

Watchlist
  • 365.960
  • -0.520-0.14%
Close Dec 20 16:00 ET
  • 365.960
  • 0.0000.00%
Post 20:01 ET
84.87BMarket Cap13.32P/E (TTM)

About Elevance Health Company

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Company Profile

SymbolELV
Company NameElevance Health
Listing DateOct 30, 2001
Founded1944
CEOMs. Gail Koziara Boudreaux
MarketNYSE
Employees104900
Fiscal Year Ends12-31
Address220 Virginia Avenue
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46204
Phone1-800-331-1476

Company Executives

  • Name
  • Position
  • Salary
  • Gail Koziara Boudreaux
  • President, Chief Executive Officer and Director
  • 21.89M
  • Blair W. Todt
  • Executive Vice President and Chief Legal and Administrative Officer
  • 8.11M
  • Mark B. Kaye
  • Executive Vice President and Chief Financial Officer
  • 12.36M
  • Ronald W. Penczek
  • Chief Accounting Officer and Controller
  • --
  • Ratnakar V. Lavu
  • Executive Vice President and Chief Digital Information Officer
  • --
  • Peter D. Haytaian
  • Executive Vice President; President, Carelon and CarelonRx
  • 6.98M
  • Charles Morgan Kendrick, Jr
  • Executive Vice President and President, Commercial and Specialty Health Benefits
  • --
  • Felicia F Norwood
  • Executive Vice President and President, Government Health Benefits
  • 6.48M
  • Elizabeth E. Tallett
  • Chairman of the Board
  • 597.83K
  • Deanna Strable-Soethout
  • Independent Director
  • 365.60K
  • Antonio Fabio Neri
  • Independent Director
  • 350.34K
  • Susan Dodson DeVore
  • Independent Director
  • 345.00K
  • Ramiro G. Peru
  • Independent Director
  • 386.76K
  • Lewis Hay, III
  • Independent Director
  • 362.53K
  • R. Kerry Clark
  • Independent Director
  • 371.42K
  • Dr. Bahija Jallal, PhD
  • Independent Director
  • 371.42K
  • Ryan M. Schneider
  • Independent Director
  • 347.28K
  • Robert L. Dixon, Jr
  • Independent Director
  • 360.34K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.